Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 7 of 7)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
6-Feb-10 Reuters Investment Profile N/A Lifevantage Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
2-Feb-10 Wall Street Transcript ,The The Wall St Transcript MANAGEMENT TURNOVER REPORT - Lifevantage Corp (LFVN) 8 $50 View Abstract
31-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Lifevantage Corp 40 $65 View Abstract
13-Jan-10 Life Science Analytics Life Science Analytics Lifevantage Corporation-Company Report 14 $115 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for MEDICAL SUPPLIES 18 $49 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala LIFEVANTAGE CP (LFVN=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala LIFEVANTAGE CP (LFVN=US) 2-weeks forecast 1 $10 View Abstract

Independent Reports (Showing 1 to 7 of 7)

Release
Date Contributor Author Title Pages Price More Info
6-Feb-10 Reuters Investment Profile N/A Lifevantage Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
2-Feb-10 Wall Street Transcript ,The The Wall St Transcript MANAGEMENT TURNOVER REPORT - Lifevantage Corp (LFVN) 8 $50 View Abstract
31-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Lifevantage Corp 40 $65 View Abstract
13-Jan-10 Life Science Analytics Life Science Analytics Lifevantage Corporation-Company Report 14 $115 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for MEDICAL SUPPLIES 18 $49 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala LIFEVANTAGE CP (LFVN=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala LIFEVANTAGE CP (LFVN=US) 2-weeks forecast 1 $10 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.